About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 45 record(s)
Req # A-2022-09230
All correspondence between PMPRB Executive Director Doug Clark and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09231
Copies of all PMPRB Board minutes and materials (briefing materials, presentations, staff recommendations) pertaining to the October 2022 revised draft Guidelines.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09622
All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Nothing to report this month
Organization: Canada Deposit Insurance Corporation
Req # A-2020-00071
Obtain a list of Privacy breaches reported to your organization by federal government departments and agencies in Canada between September 1st, 2020 and today, February 5, 2021.Organization: Office of the Privacy Commissioner of Canada
February 2022
Req # A-2020-00072
Obtain a copy of documents held by your organization that show the number of Canadian passports that have been reported lost or stolen by federal agencies since 2010.Organization: Office of the Privacy Commissioner of Canada
February 2022
Req # A-2021-00021
List of Privacy Act data breaches reported to OPC by federal institutions - Sept. 1, 2020 to Feb. 5, 2021.Organization: Office of the Privacy Commissioner of Canada
February 2022
Req # A-2020-18439
Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10646
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022